Affordable Access

Publisher Website

Experiences in fragment-based drug discovery

Authors
Journal
Trends in Pharmacological Sciences
0165-6147
Publisher
Elsevier
Volume
33
Issue
5
Identifiers
DOI: 10.1016/j.tips.2012.02.006
Disciplines
  • Biology
  • Chemistry

Abstract

Fragment-based drug discovery (FBDD) has become established in both industry and academia as an alternative approach to high-throughput screening for the generation of chemical leads for drug targets. In FBDD, specialised detection methods are used to identify small chemical compounds (fragments) that bind to the drug target, and structural biology is usually employed to establish their binding mode and to facilitate their optimisation. In this article, we present three recent and successful case histories in FBDD. We then re-examine the key concepts and challenges of FBDD with particular emphasis on recent literature and our own experience from a substantial number of FBDD applications. Our opinion is that careful application of FBDD is living up to its promise of delivering high quality leads with good physical properties and that in future many drug molecules will be derived from fragment-based approaches.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Fragment-based drug discovery.

on Journal of Computer-Aided Mole... August 2009

Fragment-based drug discovery.

on Journal of Medicinal Chemistry Jul 01, 2004

Experiences in fragment-based lead discovery.

on G Protein Coupled Receptors -... 2011

Ligand efficiency and fragment-based drug discover...

on Drug Discovery Today Jan 01, 2009
More articles like this..